Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarkers of myocyte injury in heart failure.
Latini R, Masson S. Latini R, et al. Among authors: masson s. Heart Fail Clin. 2009 Oct;5(4):529-36. doi: 10.1016/j.hfc.2009.04.008. Heart Fail Clin. 2009. PMID: 19631177
Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial.
Masson S, Latini R, Milani V, Moretti L, Rossi MG, Carbonieri E, Frisinghelli A, Minneci C, Valisi M, Maggioni AP, Marchioli R, Tognoni G, Tavazzi L; GISSI-HF Investigators. Masson S, et al. Circ Heart Fail. 2010 Jan;3(1):65-72. doi: 10.1161/CIRCHEARTFAILURE.109.881805. Epub 2009 Oct 22. Circ Heart Fail. 2010. PMID: 19850697 Clinical Trial.
The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.
Masson S, Latini R, Carbonieri E, Moretti L, Rossi MG, Ciricugno S, Milani V, Marchioli R, Struck J, Bergmann A, Maggioni AP, Tognoni G, Tavazzi L; GISSI-HF Investigators. Masson S, et al. Eur J Heart Fail. 2010 Apr;12(4):338-47. doi: 10.1093/eurjhf/hfp206. Epub 2010 Jan 22. Eur J Heart Fail. 2010. PMID: 20097683 Free article. Clinical Trial.
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.
Røysland R, Masson S, Omland T, Milani V, Bjerre M, Flyvbjerg A, Di Tano G, Misuraca G, Maggioni AP, Tognoni G, Tavazzi L, Latini R; GISSI-HF Investigators. Røysland R, et al. Among authors: masson s. Am Heart J. 2010 Aug;160(2):286-93. doi: 10.1016/j.ahj.2010.05.015. Am Heart J. 2010. PMID: 20691834 Clinical Trial.
Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.
Ghio S, Scelsi L, Latini R, Masson S, Eleuteri E, Palvarini M, Vriz O, Pasotti M, Gorini M, Marchioli R, Maggioni A, Tavazzi L; GISSI-HF investigators. Ghio S, et al. Among authors: masson s. Eur J Heart Fail. 2010 Dec;12(12):1345-53. doi: 10.1093/eurjhf/hfq172. Epub 2010 Oct 16. Eur J Heart Fail. 2010. PMID: 20952767 Free article. Clinical Trial.
Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
Latini R, Gullestad L, Masson S, Nymo SH, Ueland T, Cuccovillo I, Vårdal M, Bottazzi B, Mantovani A, Lucci D, Masuda N, Sudo Y, Wikstrand J, Tognoni G, Aukrust P, Tavazzi L; Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) and GISSI-Heart Failure (GISSI-HF) trials. Latini R, et al. Among authors: masson s. Eur J Heart Fail. 2012 Sep;14(9):992-9. doi: 10.1093/eurjhf/hfs092. Epub 2012 Jun 27. Eur J Heart Fail. 2012. PMID: 22740508 Free article. Clinical Trial.
CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials.
Ueland T, Nymo SH, Latini R, McMurray JJ, Kjekshus J, Yndestad A, Fucili A, Grosu A, Masson S, Maggioni AP, Gullestad L, Aukrust P; Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) trial; Investigators of the GISSI-Heart Failure (GISSI-HF) trial. Ueland T, et al. Among authors: masson s. Eur J Heart Fail. 2013 Jul;15(7):747-55. doi: 10.1093/eurjhf/hft031. Epub 2013 Mar 13. Eur J Heart Fail. 2013. PMID: 23487539 Free article. Clinical Trial.
n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial.
Aleksova A, Masson S, Maggioni AP, Lucci D, Fabbri G, Beretta L, Mos L, Paino AM, Nicolosi GL, Marchioli R, Tognoni G, Tavazzi L, Sinagra G, Latini R; GISSI-Heart Failure Investigators. Aleksova A, et al. Among authors: masson s. Eur J Heart Fail. 2013 Nov;15(11):1289-95. doi: 10.1093/eurjhf/hft103. Epub 2013 Jul 9. Eur J Heart Fail. 2013. PMID: 23839902 Free article. Clinical Trial.
Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials.
Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, Clemenza F, Tognoni G, Anand IS, Cohn JN, Anker SD, Tavazzi L, Latini R; GISSI-HF and Val-HeFT Investigators. Rossignol P, et al. Among authors: masson s. Eur J Heart Fail. 2015 Apr;17(4):424-33. doi: 10.1002/ejhf.240. Epub 2015 Feb 22. Eur J Heart Fail. 2015. PMID: 25704364 Free article.
456 results